statistiche ricercatore

Continente	#
NA - Nord America	808
AS - Asia	425
EU - Europa	335
SA - Sud America	61
Continente sconosciuto - Info sul continente non disponibili	17
AF - Africa	14
OC - Oceania	1
Totale	1.661

Nazione	#
US - Stati Uniti d'America	774
SG - Singapore	201
FI - Finlandia	84
CN - Cina	81
IT - Italia	73
DE - Germania	52
BR - Brasile	49
HK - Hong Kong	33
BD - Bangladesh	29
VN - Vietnam	23
FR - Francia	19
PL - Polonia	19
RU - Federazione Russa	19
CA - Canada	17
GB - Regno Unito	15
IE - Irlanda	15
IN - India	13
TR - Turchia	12
UA - Ucraina	10
ZA - Sudafrica	9
CZ - Repubblica Ceca	8
MX - Messico	8
NL - Olanda	8
PK - Pakistan	7
CO - Colombia	4
JP - Giappone	4
TW - Taiwan	4
AR - Argentina	3
IQ - Iraq	3
JM - Giamaica	3
ES - Italia	2
ET - Etiopia	2
ID - Indonesia	2
LK - Sri Lanka	2
LV - Lettonia	2
PE - Perù	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AT - Austria	1
AU - Australia	1
BS - Bahamas	1
CL - Cile	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
GE - Georgia	1
HN - Honduras	1
HR - Croazia	1
IR - Iran	1
KZ - Kazakistan	1
LT - Lituania	1
MA - Marocco	1
NG - Nigeria	1
NO - Norvegia	1
OM - Oman	1
PA - Panama	1
PH - Filippine	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SE - Svezia	1
SV - El Salvador	1
TH - Thailandia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.645

Nome	#
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy	380
COVID-19 impact on consecutive neurological patients admitted to the emergency department	273
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study	158
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses	132
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies	122
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease	121
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease	110
Heterozygous APTX mutation associated with atypical multiple system atrophy-like phenotype: A case report	101
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies	95
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis	91
Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease	78
Totale	1.661

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	68	0	0	0	0	9	4	7	5	9	6	9	19
2022/2023	87	10	8	2	4	10	15	0	11	18	1	2	6
2023/2024	92	6	0	13	4	3	33	0	5	5	1	9	13
2024/2025	317	13	2	5	48	29	22	25	14	43	28	38	50
2025/2026	744	63	67	33	81	62	70	149	52	34	51	22	60
2026/2027	147	17	20	29	81	0	0	0	0	0	0	0	0
Totale													1.661